© 2021 MJH Life Sciences and Psychiatric Times. All rights reserved.
© 2021 MJH Life Sciences™ and Psychiatric Times. All rights reserved.
April 16, 2021
Major risk factors for onset of tardive dyskinesia are considered.
March 31, 2021
What major challenges do patients with tardive dyskinesia face in their daily lives? Take the quiz and learn more.
March 30, 2021
The first study to gather unsolicited patient responses via social media finds 3 negative themes.
March 29, 2021
How could drugs that block post-synaptic dopamine 2 receptors increase the risk for tardive dyskinesia overtime?
November 05, 2020
Learn about the results of the recent study on deutetrabenazine and the ways it is helping patients with tardive dyskinesia.
May 31, 2019
There are a few things that we all agree on, as reflected in a recent consensus statement.
May 30, 2019
Numbers don’t tell the whole story, but gaining a better sense of the frequency, risks, and impact on patients’ quality of life can help improve treatment efforts and enhance outcomes.
May 22, 2019
There are ways to prevent, manage, and treat TD, and this podcast will guide you through those steps from FDA-approved medications to off-label therapies.
May 13, 2019
Once thought untreatable, we now have two FDA-approved medications for TD and a handful of off-label options. More in this research update.
Tardive dyskinesia hits affected populations hard, especially older folks with poor support systems.